Skip to main content Skip to navigation

Research Exchange

CDK7 inhibitors as a new strategy to overcome treatment resistance in ER+ metastatic breast cancer

Type

grant

Grant Number

R01 CA237414

A global leader in the fight against gynecologic cancer

LIVING LAB

Join the Living Lab Our Team Governance & Ethics Social Media Toolkit

DISCOVERY LAB

Discovery Lab How It Works Upcoming Webinars Contribute Data

ABOUT

About OCRA Get Involved Make a Donation Contact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

Privacy Terms Accessibility

CDK7 inhibitors as a new strategy to overcome treatment resistance in ER+ metastatic breast cancer